Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life, Cognitive Function, and Physical Fitness of Melanoma and NSCLC Patients Surviving More Than 2 Years After Immune Checkpoint Inhibitor Therapy

NCT03946007 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT03946007
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03946007 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life, Cognitive Function, and Physical Fitness of Melanoma and NSCLC Patients Surviving More Than 2 Years After Immune Checkpoint Inhibitor Therapy
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Completed
Start date
October 4, 2018
Completion date
May 1, 2022
Enrollment
134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, non small cell lung cancer